PRINCETON, N.J., Aug. 10 /PRNewswire-FirstCall/ -- Today Novo Nordisk announced the availability of the Norditropin (somatropin [rDNA origin] injection) NordiFlex((R)) 30 mg/3 mL, the only prefilled, preloaded pen that allows children who need a dose of growth hormone larger than 4.5 mg to take one injection instead of two. The pen holds twice the volume of, and has a higher maximum dose than, the 15 mg Norditropin NordiFlex((R)) pen, offering a more convenient option for patients who require a growth hormone dose up to 6.0 mg.
To view the Multimedia News Release, go to: http://www.prnewswire.com/mnr/novonordisk/39609/
Growth hormone deficiency exists when growth hormone, which regulates growth in children, is absent or produced in inadequate amounts. Children with growth hormone deficiency are abnormally small for their age, grow slowly, and may have immature facial features and abdominal obesity.(i) In the United States, 18,000 to 20,000 children receive recombinant growth hormone to treat growth failure.(ii)
"Life for children with growth hormone deficiency can be difficult," said Dianne Andrews, Executive Director of the MAGIC Foundation. "Teachers may treat them as though they are younger or they may be teased by their peers. Options to make treatment smooth can really help, such as the Norditropin NordiFlex((R)) 30 mg pen that's easy to handle and convenient."
The Norditropin NordiFlex((R)) 30 mg/3 mL prefilled pen was approved by the Food and Drug Administration (FDA) earlier this year and is now available. The dose can be adjusted up or down as needed in 0.1 mg increments up to 6.0 mg.
"Solutions that allow for more convenient use ultimately help make life easy for the patient," said Dr. Mark Sperling, University of Pittsburgh School of Medicine and Children's Hospital of Pittsburgh. "The Norditropin NordiFlex((R)) 30 mg/3 mL prefilled pen allows the patient or parent to adjust the dose increments."
The Norditropin NordiFlex((R)) pens can be used with NovoFine((R)) 30-gauge, NovoFine((R)) Autocover((R)) 30-gauge, and NovoFine((R)) 32-gauge Tip needles. A prescription for needles is needed in some states.
Norditropin NordiFlex((R)) is a registered trademark of Novo Nordisk Health Care AG.
About the MAGIC Foundation
The MAGIC Foundation is a national nonprofit organization created to provide support services for the families of children afflicted with a wide variety of chronic and/or critical disorders, syndromes, and diseases that affect a child's growth.
About Norditropin((R))
Norditropin((R)) (somatropin [rDNA origin] injection) is used to treat children with growth failure caused by very low or no production of growth hormone.
